最後更新 2024-11-21 16:35:52 (UTC+8)

基本分析

透過季節調整季營收,判斷美股整體趨勢,但注意股價有時候領先基本面的數據,應搭配其他領先指標判斷。

季營收趨勢 tooltip

季節調整季營收
季增率

10.7%


截至2024-09-30

基本資料

個股的基本資料,以及所屬的類股和產業。

公司介紹

業務介紹

賽諾菲及其子公司在美國、歐洲和國際上從事治療解決方案的研究、開發、製造和營銷。它通過三個部門運營:製藥、疫苗和消費者保健。該公司提供專科護理產品,包括人源化單克隆抗體;用於多發性硬化症、神經學、其他炎症性疾病、免疫學、罕見疾病、腫瘤學和罕見血液疾病的產品;糖尿病藥物;以及心血管和既有處方產品。它還供應小兒麻痺、百日咳和b型流感嗜血桿菌疫苗;以及流感、成人加強、腦膜炎和旅行及地方性疫苗。此外,該公司提供過敏、咳嗽和感冒、疼痛、肝護理、身心健康、益生菌、消化和營養產品;以及其他產品,如每日身體乳液、止癢產品、保濕和舒緩乳液、身體和腳部乳霜以及濕疹用粉末。此外,它還有多種藥品和疫苗處於開發階段。賽諾菲與葛蘭素史克公司簽有合作協議,共同開發重組新冠疫苗;並與斯坦福大學醫學院簽有研究合作和許可選擇協議,以推進免疫學和炎症的理解。它還與Prellis Biologics, Inc.簽有合作和許可選擇協議。該公司曾用名賽諾菲-安萬特,於2011年5月改名為賽諾菲。賽諾菲成立於1973年,總部位於法國巴黎。



Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.

所屬產業

所屬類股
Healthcare
所屬產業
Drug Manufacturers - General

警語

1. 資料僅供參考,不做任何獲利保證及特定股票與點位推薦建議。

2. 資料並不完整,需要完整資料請至相關網站索取。

3. 任何股市數據分析皆存在倖存者偏差。

warning